NATCO Pharma Launches Generic Blood Cancer Treatment Medicine In US

Natco Pharma has launched generic Pomalidomide capsules in the US in partnership with Breckenridge, targeting a $3.2 billion oncology market and securing 180 days of shared exclusivity.